Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2
Jeffery M. R. B. McAlpine,Gene Zhu,Nicholas Pudjihartono,Joan Teyra,Michael J. Currie,Zachary D. Tillett,Renwick C. J. Dobson,Sachdev S. Sidhu,Catherine L. Day,Adam J. Middleton
DOI: https://doi.org/10.1111/febs.17311
2024-10-31
FEBS Journal
Abstract:The ubiquitin cascade involves three families of enzymes that activate, conjugate, and ligate ubiquitin to substrate proteins. Ubiquitin attachment can promote the degradation of substrates but also has other critical roles in cells. Here, we have used phage display to discover six ubiquitin variants (UbVs) that bind to and inhibit an E2 enzyme. Our work may form the framework for the discovery of new therapeutics as well as provide new research tools. The ubiquitin‐conjugating E2 enzymes play a central role in ubiquitin transfer. Disruptions to the ubiquitin system are implicated in multiple diseases, and as a result, molecules that modulate the activity of the ubiquitin system are of interest. E2 enzyme function relies on interactions with partner proteins, and the disruption of these is an effective way to modulate activity. Here, we report the discovery of ubiquitin variants (UbVs) that inhibit the E2 enzyme, Ube2d2 (UbcH5b). The six UbVs identified inhibit ubiquitin chain building, and the structural and biophysical characterisation of two of these demonstrate they bind to Ube2d2 with low micromolar affinity and high specificity. Both characterised UbVs bind at a site that overlaps with E1 binding, while the more inhibitory UbV has an additional binding site that blocks a critical non‐covalent ubiquitin‐binding site on the E2 enzyme. The discovery of novel protein‐based ubiquitin derivatives that inhibit protein–protein interactions is an important step towards discovering small molecules that inhibit the activity of E2 enzymes. Furthermore, the specificity of the UbVs within the Ube2d family suggests that it may be possible to develop tools to selectively inhibit highly related E2 enzymes.
biochemistry & molecular biology